Herpes looks like a rash with blistering sores in its early stages. The cluster of sores can quickly merge and break open, oozing fluid and crusting. The rash can be different when found at the mouth, ...

Pictures of hives, also known as urticaria ... Chronic hive treatment usually begins with OTC antihistamines like Benadryl and Pepcid (famotidine). Severe cases may require oral corticosteroids like ...

George Negus was gutsy, strong-willed, armed with a wicked sense of humour and an opinion on everything. Especially on his abiding passion – politics. Gerald Stone in 1979 with his original ...

GSK to pay $2.2 billion to settle 93% of Zantac-related lawsuits. GSK targets £38 billion in sales by 2031, but market estimates fall short at £35.7 billion These cases account for 93% of the ...

The UK based drug firm GSK has agreed to pay up to $2.2bn (£1.7bn; €2bn) to settle claims that the heartburn drug ranitidine (previously marketed in the US as Zantac) caused cancer. The deal, ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

The discontinued version of the drug, Zantac, had triggered 80,000 lawsuits from 10 different law firms in the US and has hung over the FTSE 100 drugmaker in recent months. However, the settlement ...

Zantac, first sold in the US in 1983, was one of the best-selling medicines globally, bringing in more than $1bn (€0.91bn) in sales per year. It was also sold by Sanofi, a French drug company ...

GSK said on Thursday that it has now settled about 80,000 Zantac lawsuits in the US after reaching an agreement with 10 firms who represent 93% of the Zantac (ranitidine) state court product ...

GSK shares jumped more than 5 per cent on Thursday after the pharma giant said it will pay up to £1.7billion to settle thousands of legal cases that claimed its heartburn drug Zantac caused cancer.

Shares in British pharmaceutical giant GSK rose after the company said it resolved a vast majority of lawsuits in the U.S. claiming its discontinued heartburn medicine Zantac caused cancer.